The CDC's Advisory Committee on Immunization Practices (ACIP) voted Friday afternoon on new language for the adult and pediatric immunization schedules specific to the recent FDA-approved 2025-2026 COVID-19 vaccines. ACIP voted affirmatively for the following updates:
Adults 65 and older: Vaccination based on individual-based decision-making (also known as shared clinical decision-making).
Individuals 6 months to 64 years: Vaccination based on individual-based decision-making with an emphasis that the risk-benefit of vaccination is most favorable for individuals who are at an increased risk for severe COVID-19 disease and lowest for individuals who are not at an increased risk, according to the CDC list of COVID-19 risk factors.
NCPA
